# pathway_0061

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **D** — Secondary metabolite biosynthesis. .

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MAVVERDSDYYDSSYLADYYESLWTDHAALEDIAVYWAFFKERVLLSQSRVDSKFFLLDVGTGTGRVLHSLIDKAVNDADMSLDAMQFVGMDKSPFMLEQAQRAKQLPQEVRASWFVGTATALEDIASLADPHGKANLLIFAFSGINHLHQPGEIDQFFLSARRVLLPGGLALVSVCAPLLDIEGGDSVPNPYGQVKEVKSKRLEGILYREWETGQKIEGHLFTNSLKTDVVQVSQDGSERVIERNIHNIPLTLLTRDGLRRSAAAAKLEIIEERCIRDEVIFALRAVG

[Multiple Choices]
A. L-homoserine from L-aspartate: step 1/3. .
B. L-valine biosynthesis
C. L-isoleucine from 2-oxobutanoate: step 3/4. .
D. Secondary metabolite biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for FrzE, annotated to secondary metabolite biosynthesis. The pathway annotation cites experimental evidence from a publication on FR901483 biosynthesis, supporting choice D.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence might support a general inference about enzyme class, but it does not establish which pathway this protein participates in; the amino-acid biosynthesis choices cannot be reliably distinguished from secondary metabolite biosynthesis using the supplied sequence alone.


**Missing item-specific fact**

> The protein-specific functional assignment that FrzE participates in FR901483 secondary-metabolite biosynthesis.


**Reason**

> That pathway assignment is supported by external, protein-specific functional evidence, not by a sufficiently discriminating biological argument supplied in the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The cited functional annotation supports D; the alternatives name different amino-acid biosynthesis steps.


### Important caveats

- The supporting UniProt record exactly matches the supplied sequence, but the reviewer-only accession and annotation were not provided to the evaluated model.
- The cited evidence supports the pathway assignment; the question itself does not supply that evidence.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence might support a general inference about enzyme class, but it does not establish which pathway this protein participates in; the amino-acid biosynthesis choices cannot be reliably distinguished from secondary metabolite biosynthesis using the supplied sequence alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional assignment that FrzE participates in FR901483 secondary-metabolite biosynthesis.",
    "reason": "That pathway assignment is supported by external, protein-specific functional evidence, not by a sufficiently discriminating biological argument supplied in the question."
  },
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for FrzE, annotated to secondary metabolite biosynthesis. The pathway annotation cites experimental evidence from a publication on FR901483 biosynthesis, supporting choice D."
  },
  "important_caveats": [
    "The supporting UniProt record exactly matches the supplied sequence, but the reviewer-only accession and annotation were not provided to the evaluated model.",
    "The cited evidence supports the pathway assignment; the question itself does not supply that evidence."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The cited functional annotation supports D; the alternatives name different amino-acid biosynthesis steps."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for FrzE, annotated to secondary metabolite biosynthesis. The pathway annotation cites experimental evidence from a publication on FR901483 biosynthesis, supporting choice D.",
    "evidence_ids": ["C1", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence might support a general inference about enzyme class, but it does not establish which pathway this protein participates in; the amino-acid biosynthesis choices cannot be reliably distinguished from secondary metabolite biosynthesis using the supplied sequence alone.",
    "missing_item_specific_fact": "The protein-specific functional assignment that FrzE participates in FR901483 secondary-metabolite biosynthesis.",
    "reason": "That pathway assignment is supported by external, protein-specific functional evidence, not by a sufficiently discriminating biological argument supplied in the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The cited functional annotation supports D; the alternatives name different amino-acid biosynthesis steps."
  },
  "important_caveats": [
    "The supporting UniProt record exactly matches the supplied sequence, but the reviewer-only accession and annotation were not provided to the evaluated model.",
    "The cited evidence supports the pathway assignment; the question itself does not supply that evidence."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A7T8F1L3 (FRZE_CLASX) annotates this 289-aa protein as N-methyltransferase FrzE, a member of the FR901483 biosynthesis cluster from Cladobotryum sp. The PATHWAY comment reads 'Secondary metabolite biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33372776 (Zhang et al., JACS 2021). The benchmark sequence SHA256 matches the UniProt sequence exactly (sequence_version 1). The expected answer D is directly and experimentally supported.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a recognizable Rossmann-fold/methyltransferase motif (DVGTGTGRVLHSLID, a GxGxG pattern) characteristic of SAM-dependent methyltransferases. Options A (aspartate kinase step), B (valine biosynthesis enzymes: AHAS, ketol-acid reductoisomerase, dihydroxy-acid dehydratase, transaminase), and C (branched-chain aminotransferase step) all involve kinases, dehydrogenases, or transaminases—not methyltransferases. Methyltransferases are a hallmark tailoring enzyme class in secondary metabolite biosynthetic gene clusters. Thus, recognizing the methyltransferase fold and knowing that methyltransferases are absent from the specific amino-acid biosynthesis steps listed but common in secondary-metabolite tailoring provides a concrete reasoning path to D.


**Missing item-specific fact**

> None strictly required for elimination; however, confirming that this particular methyltransferase belongs to the FR901483 cluster (rather than a primary-metabolic methyltransferase) would require the specific database annotation. Among the four given options, the methyltransferase identity suffices to eliminate A, B, and C.


**Reason**

> A model with general knowledge of enzyme families in metabolic pathways can identify the GxGxG methyltransferase motif in the sequence, recognize that none of the amino-acid biosynthesis steps in options A–C employ methyltransferases, and conclude that D (secondary metabolite biosynthesis, where methyltransferase tailoring is ubiquitous) is the only compatible option. This constitutes a concrete biological argument from the supplied sequence and choices.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, B, and C specify named enzymatic steps in well-characterized amino-acid biosynthesis pathways whose constituent enzymes are kinases, dehydrogenases, or transaminases. A methyltransferase sequence is incompatible with all three. Option D is the only pathway category among the choices that routinely includes methyltransferases. No ambiguity among the four options.


### Important caveats

- The reviewer-only UniProt annotation (experimental, ECO:0000269) confirms the key but was not available to the evaluated model; the model must rely on sequence-motif recognition and pathway-composition knowledge.
- The GxGxG motif identification from a raw 289-aa sequence is a non-trivial pattern-recognition step; a model may or may not extract it reliably.
- The specific identity of FR901483 biosynthesis (as opposed to other secondary-metabolite methyltransferases) is not derivable from sequence alone, but is not needed to select D among the given options.
- The UniProt entry was first publicly released 2025-06-18 (Swiss-Prot reviewed 2026-01-28); the author's source snapshot is unknown, but the sequence has been stable since 2021-06-02.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a recognizable Rossmann-fold/methyltransferase motif (DVGTGTGRVLHSLID, a GxGxG pattern) characteristic of SAM-dependent methyltransferases. Options A (aspartate kinase step), B (valine biosynthesis enzymes: AHAS, ketol-acid reductoisomerase, dihydroxy-acid dehydratase, transaminase), and C (branched-chain aminotransferase step) all involve kinases, dehydrogenases, or transaminases—not methyltransferases. Methyltransferases are a hallmark tailoring enzyme class in secondary metabolite biosynthetic gene clusters. Thus, recognizing the methyltransferase fold and knowing that methyltransferases are absent from the specific amino-acid biosynthesis steps listed but common in secondary-metabolite tailoring provides a concrete reasoning path to D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required for elimination; however, confirming that this particular methyltransferase belongs to the FR901483 cluster (rather than a primary-metabolic methyltransferase) would require the specific database annotation. Among the four given options, the methyltransferase identity suffices to eliminate A, B, and C.",
    "reason": "A model with general knowledge of enzyme families in metabolic pathways can identify the GxGxG methyltransferase motif in the sequence, recognize that none of the amino-acid biosynthesis steps in options A–C employ methyltransferases, and conclude that D (secondary metabolite biosynthesis, where methyltransferase tailoring is ubiquitous) is the only compatible option. This constitutes a concrete biological argument from the supplied sequence and choices."
  },
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A7T8F1L3 (FRZE_CLASX) annotates this 289-aa protein as N-methyltransferase FrzE, a member of the FR901483 biosynthesis cluster from Cladobotryum sp. The PATHWAY comment reads 'Secondary metabolite biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33372776 (Zhang et al., JACS 2021). The benchmark sequence SHA256 matches the UniProt sequence exactly (sequence_version 1). The expected answer D is directly and experimentally supported."
  },
  "important_caveats": [
    "The reviewer-only UniProt annotation (experimental, ECO:0000269) confirms the key but was not available to the evaluated model; the model must rely on sequence-motif recognition and pathway-composition knowledge.",
    "The GxGxG motif identification from a raw 289-aa sequence is a non-trivial pattern-recognition step; a model may or may not extract it reliably.",
    "The specific identity of FR901483 biosynthesis (as opposed to other secondary-metabolite methyltransferases) is not derivable from sequence alone, but is not needed to select D among the given options.",
    "The UniProt entry was first publicly released 2025-06-18 (Swiss-Prot reviewed 2026-01-28); the author's source snapshot is unknown, but the sequence has been stable since 2021-06-02."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C specify named enzymatic steps in well-characterized amino-acid biosynthesis pathways whose constituent enzymes are kinases, dehydrogenases, or transaminases. A methyltransferase sequence is incompatible with all three. Option D is the only pathway category among the choices that routinely includes methyltransferases. No ambiguity among the four options."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0061",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A7T8F1L3 (FRZE_CLASX) annotates this 289-aa protein as N-methyltransferase FrzE, a member of the FR901483 biosynthesis cluster from Cladobotryum sp. The PATHWAY comment reads 'Secondary metabolite biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33372776 (Zhang et al., JACS 2021). The benchmark sequence SHA256 matches the UniProt sequence exactly (sequence_version 1). The expected answer D is directly and experimentally supported.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a recognizable Rossmann-fold/methyltransferase motif (DVGTGTGRVLHSLID, a GxGxG pattern) characteristic of SAM-dependent methyltransferases. Options A (aspartate kinase step), B (valine biosynthesis enzymes: AHAS, ketol-acid reductoisomerase, dihydroxy-acid dehydratase, transaminase), and C (branched-chain aminotransferase step) all involve kinases, dehydrogenases, or transaminases—not methyltransferases. Methyltransferases are a hallmark tailoring enzyme class in secondary metabolite biosynthetic gene clusters. Thus, recognizing the methyltransferase fold and knowing that methyltransferases are absent from the specific amino-acid biosynthesis steps listed but common in secondary-metabolite tailoring provides a concrete reasoning path to D.",
    "missing_item_specific_fact": "None strictly required for elimination; however, confirming that this particular methyltransferase belongs to the FR901483 cluster (rather than a primary-metabolic methyltransferase) would require the specific database annotation. Among the four given options, the methyltransferase identity suffices to eliminate A, B, and C.",
    "reason": "A model with general knowledge of enzyme families in metabolic pathways can identify the GxGxG methyltransferase motif in the sequence, recognize that none of the amino-acid biosynthesis steps in options A–C employ methyltransferases, and conclude that D (secondary metabolite biosynthesis, where methyltransferase tailoring is ubiquitous) is the only compatible option. This constitutes a concrete biological argument from the supplied sequence and choices."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C specify named enzymatic steps in well-characterized amino-acid biosynthesis pathways whose constituent enzymes are kinases, dehydrogenases, or transaminases. A methyltransferase sequence is incompatible with all three. Option D is the only pathway category among the choices that routinely includes methyltransferases. No ambiguity among the four options."
  },
  "important_caveats": [
    "The reviewer-only UniProt annotation (experimental, ECO:0000269) confirms the key but was not available to the evaluated model; the model must rely on sequence-motif recognition and pathway-composition knowledge.",
    "The GxGxG motif identification from a raw 289-aa sequence is a non-trivial pattern-recognition step; a model may or may not extract it reliably.",
    "The specific identity of FR901483 biosynthesis (as opposed to other secondary-metabolite methyltransferases) is not derivable from sequence alone, but is not needed to select D among the given options.",
    "The UniProt entry was first publicly released 2025-06-18 (Swiss-Prot reviewed 2026-01-28); the author's source snapshot is unknown, but the sequence has been stable since 2021-06-02."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7T8F1L3` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 11. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:48.298817+00:00.  

```json
"A0A7T8F1L3"
```

Source SHA-256: `8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:48.298817+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"FR901483 biosynthesis cluster protein E"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"2.1.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"N-methyltransferase FrzE"}}}
```

Source SHA-256: `8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)  
**Locator:** `/comments/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:48.298817+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"Secondary metabolite biosynthesis"}]}
```

Source SHA-256: `8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L3.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:48.298817+00:00.  

```json
{"citation":{"authors":["Zhang Z.","Tamura Y.","Tang M.","Qiao T.","Sato M.","Otsu Y.","Sasamura S.","Taniguchi M.","Watanabe K.","Tang Y."],"citationCrossReferences":[{"database":"PubMed","id":"33372776"},{"database":"DOI","id":"10.1021/jacs.0c12352"}],"citationType":"journal article","firstPage":"132","id":"33372776","journal":"J. Am. Chem. Soc.","lastPage":"136","publicationDate":"2021","title":"Biosynthesis of the Immunosuppressant (-)-FR901483.","volume":"143"},"referenceComments":[{"type":"STRAIN","value":"11231"}],"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC DNA]","FUNCTION","CATALYTIC ACTIVITY","PATHWAY"]}
```

Source SHA-256: `8bf8f6b54a22924ce3e29b7871caafa0c559fc8abe3d986ff31d11379636d5a4`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11)  
**Locator:** `lines 1-13`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-02T04:25:50.153846+00:00.  

```text
ID   FRZE_CLASX              Reviewed;         289 AA.
AC   A0A7T8F1L3;
DT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.
DT   02-JUN-2021, sequence version 1.
DT   28-JAN-2026, entry version 11.
DE   RecName: Full=N-methyltransferase FrzE {ECO:0000303|PubMed:33372776};
DE            EC=2.1.1.- {ECO:0000269|PubMed:33372776};
DE   AltName: Full=FR901483 biosynthesis cluster protein E {ECO:0000303|PubMed:33372776};
GN   Name=FrzE {ECO:0000303|PubMed:33372776};
OS   Cladobotryum sp.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Hypocreomycetidae; Hypocreales; Hypocreaceae; Cladobotryum.
OX   NCBI_TaxID=2040732;
```

Source SHA-256: `02a95973abcefb95c240893b88e697665cd99234a9c35783731b0c3171f26890`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11)  
**Locator:** `lines 14-22`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-02T04:25:50.153846+00:00.  

```text
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RC   STRAIN=11231;
RX   PubMed=33372776; DOI=10.1021/jacs.0c12352;
RA   Zhang Z., Tamura Y., Tang M., Qiao T., Sato M., Otsu Y., Sasamura S.,
RA   Taniguchi M., Watanabe K., Tang Y.;
RT   "Biosynthesis of the Immunosuppressant (-)-FR901483.";
RL   J. Am. Chem. Soc. 143:132-136(2021).
```

Source SHA-256: `02a95973abcefb95c240893b88e697665cd99234a9c35783731b0c3171f26890`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L3?format=txt&versions=11)  
**Locator:** `lines 72-73`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-02T04:25:50.153846+00:00.  

```text
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:33372776}.
```

Source SHA-256: `02a95973abcefb95c240893b88e697665cd99234a9c35783731b0c3171f26890`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 61. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
